CARA
Cara Therapeutics Inc
Price:  
0.37 
USD
Volume:  
513,610.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

CARA Relative Valuation

-9607.6%
Upside

As of 2024-07-27, the Relative Valuation of Cara Therapeutics Inc (CARA) is (35.41) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.37 USD, the upside of Cara Therapeutics Inc based on Relative Valuation is -9607.6%.

The range of the Relative Valuation is (37.42) - (22.86) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 10.1x - 10.2x 10.1x
Forward P/E multiples 16.7x - 26.2x 21.4x
Fair Price (37.42) - (22.86) (35.41)
Upside -10149.2% - -6237.8% -9607.6%
0.37 USD
Stock Price
(35.41) USD
Fair Price

CARA Relative Valuation - Historical P/E Data

Date P/E
2024-07-26 -0.17
2024-07-25 -0.16
2024-07-24 -0.16
2024-07-23 -0.17
2024-07-22 -0.16
2024-07-19 -0.15
2024-07-18 -0.15
2024-07-17 -0.15
2024-07-16 -0.17
2024-07-15 -0.15
2024-07-12 -0.16
2024-07-11 -0.16
2024-07-10 -0.13
2024-07-09 -0.13
2024-07-08 -0.13
2024-07-05 -0.13
2024-07-03 -0.12
2024-07-02 -0.12
2024-07-01 -0.12
2024-06-28 -0.12
2024-06-27 -0.14
2024-06-26 -0.13
2024-06-25 -0.15
2024-06-24 -0.15
2024-06-21 -0.12
2024-06-20 -0.11
2024-06-18 -0.11
2024-06-17 -0.11
2024-06-14 -0.16
2024-06-13 -0.20
2024-06-12 -0.30
2024-06-11 -0.30
2024-06-10 -0.30
2024-06-07 -0.28
2024-06-06 -0.29
2024-06-05 -0.31
2024-06-04 -0.30
2024-06-03 -0.30
2024-05-31 -0.29
2024-05-30 -0.27
2024-05-29 -0.28
2024-05-28 -0.30
2024-05-24 -0.30
2024-05-23 -0.33
2024-05-22 -0.34
2024-05-21 -0.34
2024-05-20 -0.33
2024-05-17 -0.33
2024-05-16 -0.36
2024-05-15 -0.34